RU95100512A - Мазь для лечения кожных заболеваний - Google Patents

Мазь для лечения кожных заболеваний

Info

Publication number
RU95100512A
RU95100512A RU95100512/14A RU95100512A RU95100512A RU 95100512 A RU95100512 A RU 95100512A RU 95100512/14 A RU95100512/14 A RU 95100512/14A RU 95100512 A RU95100512 A RU 95100512A RU 95100512 A RU95100512 A RU 95100512A
Authority
RU
Russia
Prior art keywords
ointment
treatment
skin diseases
shungite powder
vaseline
Prior art date
Application number
RU95100512/14A
Other languages
English (en)
Inventor
О.А. Рысьев
В.Н. Чечевичкин
Г.В. Селюжицкий
В.А. Пирятинская
Original Assignee
Товарищество с ограниченной ответственностью "Минеральная продукция"
Filing date
Publication date
Application filed by Товарищество с ограниченной ответственностью "Минеральная продукция" filed Critical Товарищество с ограниченной ответственностью "Минеральная продукция"
Publication of RU95100512A publication Critical patent/RU95100512A/ru

Links

Claims (1)

  1. Мазь для лечения кожных заболеваний, содержащая вазелин, отличающаяся тем, что введен шунгитовый порошок при следующем соотношении компонентов, мас. %:
    Шунгитовый порошок - 5-30
    Вазелин - Остальноее
RU95100512/14A 1995-01-10 Мазь для лечения кожных заболеваний RU95100512A (ru)

Publications (1)

Publication Number Publication Date
RU95100512A true RU95100512A (ru) 1997-11-10

Family

ID=

Similar Documents

Publication Publication Date Title
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
AU1687592A (en) 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
CA2214131A1 (en) Trisubstituted phenyl derivatives
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
BG101126A (en) The use of muramylpeptide compounds
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
HU913267D0 (en) Process for the production of 1-(3,4-dihydro-2-oxo-1h-kinoline-6-yl)-2-(4-)2-phenyl-ethyl-(piperidine-1-yl)-ethanole and ethanone, and of medical preparations containing them as active agents
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
FR2694694B1 (fr) Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
RU95100512A (ru) Мазь для лечения кожных заболеваний
NO982562D0 (no) Sammensetning for behandling av smerte
NO166642C (no) Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
RU95100513A (ru) Паста для лечения кожных заболеваний
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.